Biomea Fusion, Inc. Common Stock (BMEA) is a publicly traded Healthcare sector company. As of September 22, 2026, BMEA trades at $1.35 with a market cap of $123.95M and a P/E ratio of -6.05. BMEA moved -0.88% today. Year to date, BMEA is +37.10%; over the trailing twelve months it is -16.26%. Its 52-week range spans $0.87 to $4.43. Analyst consensus is strong buy with an average price target of $6.80. Rallies surfaces BMEA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BMEA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.35 |
| Market Cap | $123.95M |
| P/E Ratio | -6.05 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.43 |
| 52-Week Low | $0.87 |
| Volume | 1.07M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.62M |
| Net Income | $-32.54M |
| Gross Margin | 0.00% |
5 analysts cover BMEA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.80.